EC Healthcare Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Profit Before Tax
11.00
123.00
322.00
260.00
360.00
446.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-47.00
-168.00
-134.00
80.00
13.00
-221.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
645.00
608.00
603.00
616.00
574.00
254.00
Cash Flow from Investing Activities
-512.00
-715.00
-586.00
-366.00
314.00
-15.00
Cash Flow from Financing Activities
-289.00
-51.00
-80.00
158.00
-735.00
-166.00
Net Cash Inflow / Outflow
-156.00
-160.00
-60.00
410.00
153.00
71.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
-1.00
1.00
2.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of EC Healthcare
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
11.448
27.6444553123344
-16.00
-58.59%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-47.591
18.8936846794815
-65.00
-351.89%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
645.888
59.2821070366125
586.00
989.52%
Cash Flow from Investing Activities
-512.106
-343.37369092114
-169.00
-49.14%
Cash Flow from Financing Activities
-289.5
-4.79552205539692
-285.00
-5936.88%
Net Cash Inflow / Outflow
-156.234
-283.833538610012
127.00
44.96%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.516
5.05356732991296
-5.00
-110.21%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'24
YoY Growth in year ended Mar 2024 is 6.18% vs 0.80% in Mar 2023
Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
645.89
608.32
6.18%






